Cargando…
Kunxian capsule alleviates podocyte injury and proteinuria by inactivating β-catenin in db/db mice
BACKGROUND: Diabetic kidney disease (DKD) remains the primary cause of end-stage renal disease (ESRD) globally, but treatment options are limited. Kunxian capsule (KXC) has been utilized for the treatment of autoimmune diseases and IgA nephropathy in China. However, its effect on DKD remains poorly...
Autores principales: | Jin, Bo, Liu, Jing, Zhu, Yan, Lu, Jian, Zhang, Qingyan, Liang, Yan, Shao, Qiuyuan, Jiang, Chunming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349331/ https://www.ncbi.nlm.nih.gov/pubmed/37457567 http://dx.doi.org/10.3389/fmed.2023.1213191 |
Ejemplares similares
-
Quantifying Podocyte Number in a Small Sample Size of Glomeruli with CUBIC to Evaluate Podocyte Depletion of db/db Mice
por: Shi, Jiaoyu, et al.
Publicado: (2023) -
Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy
por: Le, Wei-Bo, et al.
Publicado: (2022) -
Network Pharmacology-Based Analysis on the Curative Effect of Kunxian Capsules against Rheumatoid Arthritis
por: Yan, Hong-Xia, et al.
Publicado: (2021) -
Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice
por: Liang, Yiran, et al.
Publicado: (2020) -
NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice
por: Yang, Shu, et al.
Publicado: (2018)